The effects of GM-CSF, steel factor and MIP-1α on the expression and activation of Cdc25A phosphatase in mo7e cells

Cytokines, Cellular and Molecular Therapy

Volumn 5, Issue 3, 1999, Pages 129-138

  Reid, Suzanna ^a   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell proliferation; GM CSF; MIP 1 ; Mo7e; Steel factor

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NUCLEAR PROTEIN; PHOSPHATASE; PHOSPHOTYROSINE; STEEL FACTOR;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CDC25 PHOSPHATASE; CELL DIVISION; CELL LINE; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; PHOSPHORYLATION; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS; STEM CELL FACTOR;

EID: 0032886866     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Galaktionov K, Beach D, Specific activation of cdc25 tyrosine phosphatases by B-type cyclins. Cell (1991) 67: 1181-4.
2. Sadhu K, Reed SI, Richardson H, Russell P, Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci USA (1990) 87: 5139-43.
3. Hoffman I, Karsenti E, The role of cdc25 in checkpoints and feedback controls in the eukaryotic cell cycle. J Cell Sci Suppl (1994) 18: 75-9.
4. Jinno S, Kimihiko S, Nagata A et al, Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J (1994) 13: 1549-56.
5. Hoffman I, Clarke PR, Marcote MJ et al, Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J (1993) 12: 53-63.
6. 1/S transition. EMBO J (1994) 13: 4302-10.
7. Hunter T, Pines J, Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell (1994) 79: 573-82.
8. Sherr CJ, G1 phase progression: cycling on cue. Cell (1994) 79: 551-5.
9. Morgan DO, Principles of CDK regulation. Nature (1995) 379: 131-4.
10. Elledge SJ, Cell cycle checkpoints: preventing an identity crisis. Science (1996) 274: 1664-72.
11. King RW, Deshaies RJ, Peters JM, Kirscher MW, How proteolysis drives the cell cycle. Science (1996) 274: 1652-9.
12. Nasmyth K, Viewpoint: putting the cell cycle in order. Science (1996) 274: 1643-5.
13. Sherr CJ, Cancer cell cycle. Science (1996) 274: 1672-7.
14. Stillman B, Cell cycle control of DNA replication. Science (1996) 274: 1659-64.
15. Fesquet D, Labbe JC, Derancourt J et al, The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J (1993) 12: 3111-21.
16. Matsuoka M, Kato JY, Fisher RP et al, Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol Cell Biol (1994) 14: 7265-75.
17. cdc2 activation: identification of an activating kinase. Mol Biol Cell (1992) 3: 13-27.
18. Terada Y, Tatsuka M, Jinno S, Okayama H, Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature (1995) 376: 358-62.
19. Poon RY, Jiang W, Toyoshima H, Hunter T, Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J Biol Chem (1996) 271: 13283-91.
20. Gu Y, Rosenblatt J, Morgan DO, Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J (1993) 11: 3995-4005.
21. Sebastian B, Kakizuka A, Hunter T, Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci USA (1993) 90: 3521-4.
22. cdc2 kinase in fission yeast. EMBO J (1991) 10: 4301-9.
23. cdc2. Cell (1991) 67: 197-211.
24. Dunphy WG, Kumagai A, The cdc25 protein contains an intrinsic phosphatase activity. Cell (1991) 67: 189-96.
25. Iavarone A, Massague J, Repression of the CDK activator Cdc25a and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature (1997) 387: 417-22.
26. Galaktionov K, Chen X, Beach D, Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (1996) 382: 511-17.
27. Clarke PR, Hoffman I, Draetta G, Karsenti E, Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts. Mol Biol Cell (1993) 4: 397-411.
28. 0-like arrest. Mol Cell Biol (1996) 16: 3934-44.
29. Wickramasinghe D, Becker S, Ernst MK et al, Two CDC25 homologues are differentially expressed during mouse development. Development (1995) 121: 2047-56.
30. Sanchez Y, Wong C, Thoma RS et al, Conservation of the chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through cdc25. Science (1997) 277: 1497-501.
31. Weinert T, A DNA damage checkpoint meets the cell cycle engine. Science (1997) 277: 1450-1.
32. Furnari B, Rhind N, Russell P, Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science (1997) 277: 1495-7.
33. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (1997) 277: 1501-5.
34. Hendrie PC, Miyazawa K, Yang YC et al, Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line, M07e. Exp Hematol (1991) 19: 1031-7.
35. Miyazawa K, Hendrie PC, Mantel C et al, Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase. Exp Hematol (1991) 19: 1110-23.
36. Hallek M, Druker B, Lepisto EM et al, Granulocyte-macrophage colony-stimulating factor and steel factor induce phosphorylation of both unique and overlapping signal transduction intermediates in a human factor-dependent hematopoietic cell line. J Cell Physiol (1992) 153: 176-86.
37. Horie M, Broxmeyer HE, Involvement of immediate-early gene expression in the synergistic effects of steel factor in combination with granulocyte-macrophage colony-stimulating factor or interleukin-3 on proliferation of a human factor-dependent cell line. J Biol Chem (1993) 268: 968-73.
38. Broxmeyer HE, Benninger L, Hague N et al, Suppressive effects of the chemokine (macrophage inflammatory protein) family of cytokines on proliferation of normal and leukemia myeloid cell proliferation. In: The Negative Regulation of Hematopoiesis from Fundamental Aspects to Clinical Applications (M Guigon, FM Lemoine, N Cainiak et al). Inserm Eurotext Libbey, Paris (1993) Vol 229, 141-154.
39. Broxmeyer HE, Cooper S, Hague N et al, Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line in vivo in mice. Ann Hematol (1995) 71: 235-46.
40. Graham GJ, Wright EG, Hewick K et al, Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature (1990) 344: 442-4.
41. Broxmeyer HE, Sherry B, Lu L et al, Enhancer and suppressive effects of recombinant murine macrophage inflammatory protein on colony formation in vitro by bone marrow myeloid progenitor cells. Blood (1990) 76: 1110-16.
42. Broxmeyer HE, Kim CH, Chemokines and hematopoiesis. In: Chemokines and Cancer (ed BJ Rollins) 263-91. Humana Press, New Jersey, 1999.
43. Broxmeyer HE, Kim CH, Regulators of hematopoiesis in a sea of chemokine family members with a plethera of redundant activities. Exp Hematol (1999) 27: 1113-23.
44. Girard F, Strausfeld U, Cavadore JC et al, Cdc25 is a nuclear protein expressed constitutively throughout the cell cycle in nontransformed mammalian cells. J Cell Biol (1992) 118: 785-94.
45. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ, Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell (1991) 65: 701-13.
46. 1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol (1994) 14: 2077-86.
47. 1 progression by CSF-1. Mol Reprod Dev (1997) 46: 11-18.
48. Reed SI, Control of the G1/S transition. Cancer Surv (1997) 29: 7-23.
49. 1S-regulating genes in human cancer. Prog Cell Cycle Res (1997) 3: 211-20.
50. Danova M, Aglietta M, Cytokine receptors, growth factors and cell cycle in human bone marrow and peripheral blood hematopoietic progenitors. Haematologica (1997) 82(5): 622-9.
51. Alexander WS, Cytokines in hematopoiesis. Int Rev Immunol (1998) 16: 651-82.
52. Ogawa M, Hematopoiesis. J Allergy Clin Immunol (1994) 94: 645-50.
53. Lowry PA, Hematopoietic stem cell cytokine response. J Cell Biochem (1995) 58: 410-15.
54. Rollins BJ, Chemokines. Blood (1997) 90: 909-28.
55. Broxmeyer HE, Myelosuppressive cytokines and peptides. In: Blood Cell Biochemistry, Vol 7: Hemopoietic Growth Factors (ed T Whetton, T Gordon) 121-50. Plenum, London, 1996.
56. Coleman TR, Dunphy G, Cdc2 regulatory factors. Curr Opin Cell Biol (1994) 6: 877-82.
57. Parsons R, Phosphatases and tumorigenesis. Curr Opin Oncol (1998) 10: 88-91.
58. CDC25 is a nuclear protein required for the initiation of mitosis in human cells. Proc Natl Acad Sci USA (1991) 18: 10500-4.
59. Galaktionov K, Lee AK, Eckstein J et al, CDC25 phosphatases as potential human oncogenes. Science (1995) 269: 1575-7.